Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03770169 · ClinicalTrials.gov registry record
Validation of Patient Reported Outcome Measures for Use in Vulvodynia
A clinical trial of Vulvodynia, sponsored by Ipsen.
- Completed
- Registry status
- 20
- Enrollment target
- 4
- Study locations
NCT03770169: Completed study of Vulvodynia, sponsored by Ipsen.
NCT03770169 is a study of Vulvodynia that has completed, run by Ipsen. The registered enrollment target is 20 participants, below the 136-participant average among 9 other Vulvodynia trials with a reported enrollment target (85% lower). The trial reports 4 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03770169, a study of Vulvodynia, has completed, sponsored by Ipsen.
- COMPLETED
- Registry status
- 20 participants
- Enrollment target
- 4
- Study locations
Study Summary
The overall aim of this project is to demonstrate content validity and usability of the modified Vulvar Pain Assessment Questionnaire (mVPAQ), the modified Female Sexual Function Index (mFSFI), and pain on intercourse Numeric Rating Scale (NRS) for adult patients with Vulvodynia
Primary Outcome
Cognitive debrief and usability through interviews and completion of an electronic diary
Conditions Studied
Study Locations (4)
California
- San Diego Sexual Medicine - San Diego
District of Columbia
- Center for Vulvovaginal Disorders - Washington D.C.
Nebraska
- Omaha OB-GYN Associates, PC - Omaha
New York
- The Center for Vulvovaginal Disorders - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2019-02-18 |
| Est. Completion | 2019-09-19 |
What the finished NCT03770169 record still lists
NCT03770169 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 136-participant average among 9 other Vulvodynia trials with a reported enrollment target (85% lower).
The record links to 1 condition, with Vulvodynia appearing as the primary indexed condition, and to 0 interventions.
NCT03770169 reports a single indexed study location in California, District of Columbia, Nebraska.
Frequently Asked Questions
What is clinical trial NCT03770169 about?
NCT03770169 is a clinical study titled "Validation of Patient Reported Outcome Measures for Use in Vulvodynia". The overall aim of this project is to demonstrate content validity and usability of the modified Vulvar Pain Assessment Questionnaire (mVPAQ), the modified Female Sexual Function Index (mFSFI), and pain on intercourse Numeric Rating Scale (NRS) for adult patients with Vulvodynia
What is the current status of trial NCT03770169?
This trial is currently completed. The enrollment target is 20 participants. The study started on 2019-02-18. Estimated completion is 2019-09-19.
What conditions does trial NCT03770169 study?
This clinical trial studies the following conditions: Vulvodynia.
Who is sponsoring clinical trial NCT03770169?
This trial is sponsored by Ipsen, which has 85 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03770169 being conducted?
This trial has 4 study locations across California, District of Columbia, Nebraska, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Vulvodynia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03770169's enrollment target sits among peer trials
20 8th of 9 higher than 2 of 9 other Vulvodynia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Vulvodynia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Vestibulectomy Surgical Techniques Comparison Study
RECRUITING · NA
-
Topical Ketotifen 0.25% for Secondary Vestibulodynia
RECRUITING · Phase 2
-
Prospective Data Bank Creation to Study Vaginal Conditions
RECRUITING
-
Acupuncture for Vulvodynia: A Pre-pilot Study
COMPLETED · NA
-
Acupuncture for the Treatment of Vulvodynia
COMPLETED · NA
-
Profiling Vulvodynia Based on Neurobiological and Behavioral Endophenotypes
COMPLETED
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI